Nobel laureate Carolyn Bertozzi to rejoin Lilly boardnews2025-11-24T09:15:20+00:00November 24th, 2025|Endpoints News|
Top Makary aide Jain-Nagpal remains at the FDA after White House pushbacknews2025-11-21T20:25:04+00:00November 21st, 2025|Endpoints News|
AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the USnews2025-11-21T19:33:41+00:00November 21st, 2025|Endpoints News|
Teva loses IRA drug pricing challenge in DC federal court news2025-11-21T19:19:47+00:00November 21st, 2025|Endpoints News|
FDA investigates child death potentially related to Takeda’s enzyme replacement therapynews2025-11-21T16:11:24+00:00November 21st, 2025|Endpoints News|
Novo, Lilly begin to sell obesity medications directly to employersnews2025-11-21T15:56:08+00:00November 21st, 2025|Endpoints News|
Lilly becomes first $1 trillion pharma companynews2025-11-21T15:24:53+00:00November 21st, 2025|Endpoints News|
GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing dealnews2025-11-21T12:07:36+00:00November 21st, 2025|Endpoints News|
Under RFK Jr., vaccine use has slid while suspicion risesnews2025-11-20T20:47:17+00:00November 20th, 2025|Endpoints News|
Pentagon-backed Lumen is ready to drastically slash antibody manufacturing costsnews2025-11-20T20:46:37+00:00November 20th, 2025|Endpoints News|
